BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 6130585)

  • 41. Sphingolipidoses in Turkey.
    Ozkara HA; Topçu M
    Brain Dev; 2004 Sep; 26(6):363-6. PubMed ID: 15275696
    [TBL] [Abstract][Full Text] [Related]  

  • 42. An enzymological approach to the lipidoses.
    Tallman JF; Pentchev PG; Brady RO
    Enzyme; 1974; 18(1):136-49. PubMed ID: 4211795
    [No Abstract]   [Full Text] [Related]  

  • 43. Inborn errors of metabolism.
    Kolodny EH; Cable WJ
    Ann Neurol; 1982 Mar; 11(3):221-32. PubMed ID: 6807191
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Enzyme transplants.
    Lancet; 1972 Dec; 2(7789):1235-6. PubMed ID: 4117717
    [No Abstract]   [Full Text] [Related]  

  • 45. Ex vivo cell-mediated gene therapy for metachromatic leukodystrophy using neurospheres.
    Kawabata K; Migita M; Mochizuki H; Miyake K; Igarashi T; Fukunaga Y; Shimada T
    Brain Res; 2006 Jun; 1094(1):13-23. PubMed ID: 16729983
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Enzyme replacement improves nervous system pathology and function in a mouse model for metachromatic leukodystrophy.
    Matzner U; Herbst E; Hedayati KK; Lüllmann-Rauch R; Wessig C; Schröder S; Eistrup C; Möller C; Fogh J; Gieselmann V
    Hum Mol Genet; 2005 May; 14(9):1139-52. PubMed ID: 15772092
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Computer assisted small-scale Tay-Sachs carrier screening.
    Toney JH; Quirk JM
    J Appl Biochem; 1983; 5(1-2):25-30. PubMed ID: 6236193
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Stabilization of juvenile metachromatic leukodystrophy after bone marrow transplantation: a 13-year follow-up.
    Görg M; Wilck W; Granitzny B; Suerken A; Lukacs Z; Ding X; Schulte-Markwort M; Kohlschütter A
    J Child Neurol; 2007 Sep; 22(9):1139-42. PubMed ID: 17890417
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Enzyme therapy in Fabry's disease by renal transplantation.
    Desnick RJ; Raman M; Allen KY; Desnick SJ; Simmons RL; Anderson CF; Woods JE; Najarian JS; Krivit W
    Proc Clin Dial Transplant Forum; 1972; 2():27-35. PubMed ID: 4219812
    [No Abstract]   [Full Text] [Related]  

  • 50. Allotransplantation for the treatment of inborn errors of metabolism.
    Nadler HL
    Ann Intern Med; 1972 Aug; 77(2):314-6. PubMed ID: 4565793
    [No Abstract]   [Full Text] [Related]  

  • 51. When an inhibitor promotes activity.
    Bouvier M
    Chem Biol; 2007 Mar; 14(3):241-2. PubMed ID: 17379138
    [No Abstract]   [Full Text] [Related]  

  • 52. Tay-Sachs disease: the search for the enzymatic defect.
    Brady RO
    Adv Genet; 2001; 44():51-60. PubMed ID: 11596998
    [No Abstract]   [Full Text] [Related]  

  • 53. Hematopoietic Stem Cell Transplantation for Children With Inborn Errors of Metabolism: Single Center Experience Over Two Decades.
    Swaminathan VV; Meena S; Varla H; Chandar R; Jayakumar I; Ramakrishnan B; Uppuluri R; Raj R
    Indian Pediatr; 2022 Sep; 59(9):699-702. PubMed ID: 35762023
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Diagnosis of myelin disorders by the biochemical analysis of tears.
    Van Hoof F; Campoy C
    Bull Soc Belge Ophtalmol; 1983 Nov; 208 Pt 1():291-5. PubMed ID: 6144340
    [No Abstract]   [Full Text] [Related]  

  • 55. Changes of serum hexosaminidase for the presumptive diagnosis of type I Gaucher disease in Tay-Sachs carrier screening.
    Nakagawa S; Kumin S; Sachs G; Nitowsky HM
    Am J Med Genet; 1983 Mar; 14(3):525-32. PubMed ID: 6859103
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Partial cure of established disease in an animal model of metachromatic leukodystrophy after intracerebral adeno-associated virus-mediated gene transfer.
    Sevin C; Verot L; Benraiss A; Van Dam D; Bonnin D; Nagels G; Fouquet F; Gieselmann V; Vanier MT; De Deyn PP; Aubourg P; Cartier N
    Gene Ther; 2007 Mar; 14(5):405-14. PubMed ID: 17093507
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Towards enzyme replacement in GM2 gangliosidosis: organ disposition and induced central nervous system uptake of human beta-hexosaminidase in the cat.
    Rattazzi MC; Lanse SB; McCullough RA; Nester JA; Jacobs EA
    Birth Defects Orig Artic Ser; 1980; 16(1):179-93. PubMed ID: 6778524
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Advances in the treatment of inherited metabolic diseases.
    Desnick RJ; Grabowski GA
    Adv Hum Genet; 1981; 11():281-369. PubMed ID: 6115548
    [No Abstract]   [Full Text] [Related]  

  • 59. Prospects for enzyme replacement therapy in Gaucher disease.
    Brady RO; Barranger JA; Furbish FS; Stowens DW; Ginns EI
    Prog Clin Biol Res; 1982; 95():669-80. PubMed ID: 7122643
    [No Abstract]   [Full Text] [Related]  

  • 60. [Enzymes of glycolipid metabolism and their role in the development of glycolipidoses].
    Mkheian EE
    Vestn Akad Med Nauk SSSR; 1983; (4):71-7. PubMed ID: 6306946
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.